CTLA-4 Blockade of Natural Killer Cells Increases Cytotoxicity against Acute Lymphoid Leukaemia Cells Neda

Objective: There is interest in using cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy to treat blood cancers.Unfortunately, patients with acute lymphoblastic leukaemia (ALL) frequently exhibit resistance to treatment and naturalkiller (NK) cell exhaustion. This study aims to increase the cyt...

Full description

Bibliographic Details
Main Authors: Neda Parvini, Mohammad Esmaeil Akbari, Amir Ali Hamidieh, Fardin Fathi, Abbas Ali Amini, Marzieh Ebrahimi, Zakaria Vahabzadeh
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2024-02-01
Series:Cell Journal
Subjects:
Online Access:https://www.celljournal.org/article_710008_7d80dc9dae311eeda26d9759146ed7bc.pdf

Similar Items